From May 2014 through September 2019 a total of 109 patients with de-novo diagnosis of oligometastatic PCa or diagnosis of oligoprogressive PCa were treated with PSMA-PET/CT-guided radiotherapy. The gene discussed is FOLH1; the disease is posterior cortical atrophy.